Diabetes Treatment Denied in Australia: Appeal Guide
Diabetes treatment denied in Australia? Learn NDSS rights, CGM PBS subsidies, insulin pump funding criteria, private insurer appeals, and AFCA complaints.
Living with diabetes in Australia involves navigating a complex mix of government subsidy programs, private health insurance, and specialist care. When an insurer or government program denies access to essential diabetes technology or treatment, it can directly compromise your health. Here is how to understand and fight a denial.
How Diabetes Treatment Is Covered in Australia
National Diabetes Services Scheme (NDSS): The NDSS, administered by Diabetes Australia under contract with the Australian Government, subsidises a range of diabetes consumables — including blood glucose testing strips, insulin syringes, needles, and lancets — for people with diagnosed diabetes who are registered with the scheme. Registration is free and available at ndss.com.au.
Continuous Glucose Monitoring (CGM) on the PBS: Since 2022, the Australian Government has progressively expanded PBS subsidies for CGM devices. Libre 2 sensors are now PBS-subsidised for people with Type 1 diabetes (and some other insulin-requiring conditions) who meet the eligibility criteria. The criteria require a current prescription and registration. If you are being denied access or subsidy, it is often because the prescribing GP or endocrinologist has not used the correct PBS item number or the wrong CGM product is listed.
Insulin pumps: Continuous subcutaneous insulin infusion (CSII) — insulin pump therapy — is available with a government subsidy for eligible people with Type 1 diabetes. The Program of Appliances for Disabled People (PADP) in some states and the National Diabetes Services Scheme both have components for pump consumables. Pump eligibility criteria vary and can be a source of denial, particularly for children and adolescents.
Private health insurance: Private health cover for diabetes relates primarily to hospital admissions — for example, diabetic ketoacidosis management, foot surgery, eye surgery for diabetic retinopathy, or kidney-related complications. Private insurers do not fund CGM devices or insulin pumps directly; those fall under government programs.
Common Reasons Diabetes Claims Are Denied
- PBS CGM eligibility criteria not met: If your diagnosis is Type 2 rather than Type 1, CGM may not be PBS-subsidised even if clinically indicated.
- Incorrect item number on prescription: CGM prescriptions require specific PBS item numbers. A prescription lacking the right item code will be rejected at the pharmacy.
- Private hospital admission denied: Your private health insurer may deny admission for diabetes-related complications if the treating physician did not obtain pre-authorisation.
- NDSS registration gap: If you are not registered with the NDSS, consumable subsidies are unavailable until you register — sometimes causing supply delays.
- Waiting period for PHI: New private health insurance members face a 2-month general waiting period; diabetes complications treated within this period may be denied.
How to Appeal a Diabetes Coverage Denial
PBS/CGM prescription issues: Return to your GP or endocrinologist and request they check the prescribing requirements on the PBS website. The item must match your eligible diagnosis. If there is a clinical case for CGM that does not meet current PBS criteria, your doctor can apply for a Special Access Scheme or Exceptional Drug program.
Private insurer — internal review: Submit a written internal appeal to your private health insurer. Include a letter from your endocrinologist or treating physician explaining why hospitalisation or the denied treatment was medically necessary.
AFCA complaint: If your private health insurer's internal review fails, escalate to the Australian Financial Complaints Authority (AFCA). AFCA resolves private health insurance disputes, including for diabetes-related hospital claims. Lodge at afca.org.au.
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
Private Health Insurance Ombudsman (PHIO): The PHIO handles disputes specifically about private health insurance. Contact them at privatehealth.gov.au.
NDSS — Diabetes Australia helpline: Diabetes Australia operates the NDSS helpline at 1800 637 700. They can assist with scheme registration issues, product eligibility queries, and navigating consumable access problems.
Insulin Pump Funding for Children
For children under 18 with Type 1 diabetes, insulin pump therapy may be available at no cost through the Insulin Pump Program for Children and Adolescents, administered through state-based health networks. If your child has been denied a pump or pump consumables, contact your state children's hospital endocrinology department and Diabetes Australia for support navigating the funding pathway.
Key Support Organisations
Diabetes Australia (diabetesaustralia.com.au) provides comprehensive resources on NDSS, CGM access, insulin pumps, and insurance navigation. Their state-based offices can provide individual advocacy support.
JDRF Australia (jdrf.org.au) focuses on Type 1 diabetes and maintains updated information on PBS technology subsidies.
Fight Back With ClaimBack
ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.
Fight your denial at ClaimBack →
Related Reading:
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides